| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $571.9M | — | +7.8% |
| Cost of Revenue | $87.3M | — | +3.2% |
| Gross Profit | $484.5M | — | +8.7% |
| R&D Expense | $60.7M | — | -2.6% |
| SG&A Expense | $274.3M | — | +5.2% |
| Operating Income | $210.2M | — | +13.6% |
| Interest Expense | $4.0M | — | +400.0% |
| Pre-tax Income | $215.3M | — | +13.1% |
| Income Tax | $59.5M | — | +16.9% |
| Net Income | $155.7M | — | +11.7% |
| EPS (Basic) | $3.05 | — | +22.5% |
| EPS (Diluted) | $3.04 | — | +22.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $153.9M | -58.4% | -70.4% |
| Accounts Receivable | $51.3M | +14.3% | +63.9% |
| Inventory | $1.5M | -11.8% | +7.1% |
| Current Assets | $3.07B | -47.4% | +2.8% |
| Total Assets | $4.82B | -36.5% | +5.4% |
| Current Liabilities | $2.84B | -47.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $213.8M | — | +17.2% |
| Capital Expenditures | $31.2M | — | -17.2% |
| Investing Cash Flow | -$30.8M | — | +91.9% |
| Financing Cash Flow | -$2.91B | — | -100.5% |
| Free Cash Flow | $182.6M | — | +26.1% |
| +14.4% |
| Long-term Debt | $675.0M | — | — |
| Total Liabilities | $4.01B | -31.7% | +40.4% |
| Stockholders' Equity | $811.7M | -53.1% | -52.7% |